{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"13.14","upperLimit":"21.25","value":"17.21"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"title":"Baseline - Physical Well-Being"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"21.40","upperLimit":"25.92","value":"23.66"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"title":"Baseline - Social/Family Well-Being"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"14.30","upperLimit":"19.70","value":"17.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"title":"Baseline - Emotional Well-Being"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"14.00","upperLimit":"20.95","value":"17.48"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"title":"Baseline Functional Well-Being"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"65.84","upperLimit":"84.86","value":"75.35"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"title":"Baseline Total Fact-G Score"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"18.67","upperLimit":"27.83","value":"23.25"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"title":"Baseline Additional Concerns"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"48.05","upperLimit":"67.82","value":"57.94"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"title":"Total Outcome Index Score - Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"10.59","upperLimit":"20.52","value":"15.56"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"title":"Pre-RT Physical Well-Being"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"21.24","upperLimit":"26.56","value":"23.90"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"title":"Pre-RT Social/Family Well-Being"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"15.55","upperLimit":"22.05","value":"18.80"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"title":"Pre-RT Emotional Well-Being"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"11.55","upperLimit":"19.72","value":"15.63"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"title":"Pre-RT Functional Well-Being"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"59.13","upperLimit":"84.87","value":"72.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"title":"Pre-RT Total Fact-G Score"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"20.43","upperLimit":"30.46","value":"25.44"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"title":"Pre-RT Additional Concerns"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"44.79","upperLimit":"66.76","value":"55.78"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"title":"Total Outcome Index Score - Pre-RT"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"20.74","upperLimit":"26.86","value":"23.80"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"title":"Post-RT Social/Family Well-Being"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"11.08","upperLimit":"21.75","value":"16.42"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"title":"Post-RT Physical Well-Being"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.10","upperLimit":"21.77","value":"18.93"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"title":"Post-RT Emotional Well-Bein"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"10.72","upperLimit":"21.11","value":"15.92"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"title":"Post-RT Functional Well-Being"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"60.17","upperLimit":"89.97","value":"75.07"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"title":"Post-RT FACT-G Total Score"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"15.40","upperLimit":"27.16","value":"21.28"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"title":"Post-RT Additional Concerns"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-22.63","upperLimit":"122.63","value":"50.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"title":"Total Outcome Index Score - Post- RT"}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"description":"Four subscales: physical well-being (PWB; 7-items, score range 0-28), social/family well-being (SWB; 7-items, score range 0-28), emotional well-being (EWB; 6-items, score range 0-24), and functional well-being (FWB; 7-items, score range 0-28). Items are rated on a five-point scale: 0-\"not at all\", 1- \"a little bit\", 2-\"somewhat\", 3- \"quite a bit\" and 4-\"very much\". Overall quality of life is the sum of the core items of the FACT-G possible range of 0-108 points. The higher the score the better the quality life. This interval includes 0, we will conclude that there is not conclusive statistical evidence that there is an improvement or worsening. If the interval does not include 0 we can determine whether there was a significant improvement (or worsening) depending on which side of the 0 the interval is on. The total outcome index score (possible range 0-108 points) is the sum of the physical and functional well being and additional concerns categories from the FACT-G.","dispersionType":"95% Confidence Interval","groups":[{"description":"Taxotere/Cisplatinum/5-Fluorouracil (TPF) Chemotherapy Followed by Concomitant Cetuximab \\& Radiation Therapy\n\ncetuximab\n\ncisplatin\n\ndocetaxel\n\nfluorouracil\n\ncomputed tomography\n\npositron emission tomography\n\nquality-of-life assessment\n\n3-dimensional conformal radiation therapy\n\nintensity-modulated radiation therapy","id":"OG000","title":"TPFChemotherapy + Concomitant Cetuximab & RT"}],"paramType":"MEAN","populationDescription":"This data was not collected on all participants.","reportingStatus":"POSTED","timeFrame":"Baseline, pre-radiation therapy and post-radiation therapy, up to 2 years","title":"Quality of Life - Functional Assessment of Cancer Therapy - General (FACT-G)","type":"SECONDARY","unitOfMeasure":"Score on a scale"}